The EU Drugs Strategy aims to create a balanced approach to supply, demand and harm reduction strategies. The project’s aim is to help support EU cities develop local, partnership based drug policies involving the relevant stakeholders – local authorities, health services criminal justice services, communities, including visible minority ones, and drug service users – so that a coordinated, participative, targeted, and thus resource effective approach can be developed towards drug-related problems.


The project aims at setting up a surveillance system to monitor the occurrence of urinary incontinence (UI) in women in the EU. The project will focus on incontinence as a consequence of inefficient or inappropriate obstetric care, with the ultimate view to formulate appropriate strategies, policies and actions to avoid these conditions, and thus improve the quality of life of particular sections of the female population.


Promovax’s general objective is to promote immunizations among migrant populations in Europe, thus contributing to the elimination of vaccine preventable diseases in the region & reducing social inequalities in health. It aims to complement EU policies on reaching hard-to-reach populations by adding to the knowledge of migrants` immunization barriers, developing educational material for both health professionals & migrants and by developing recommendations for policy-makers.
It aims to:
Identify & record the immunization needs of migrants
Evaluate migrants’ access to immunization in the EU countries
Analyze the legislative context regarding migrant immunizations in the partner countries
Identify & exchange best practices on migrants` immunization health promotion
Enhance health care professionals’ knowledge on immunization needs of migrants and raise cultural sensitivity among health care professionals providing for migrants
Improve migrants’ understanding & acceptance of immunizations and facilitate their access to immunizations by identifying a network of relevant sites.


General objective
The aim of the project is to improve health crisis communication to strengthen health security during emergencies. An effective communication strategy will increase population compliance with public health recommendations. This objective will be achieved through the drawing up of guidelines for health crisis communication and the improvement of the European network dedicated to it. We intend to produce guidelines starting from the analysis of existing ones intregating them with lessons learnt from recent crisis like the EHEC outbreak and Fukujima event. These actions will allow effective communication strategies by the key stakeholders involved in health crisis management. In particular, we will consider the need of a European approach to the problem, in the context of the Health Security Committee of the Communicators` Network, interaction with key stakeholders, an analysis of at-risks groups, and the use of new social media. We intend to collaborate with other EU and WHO agencies as well as with other existing project financed by other DGs on crisis (RTD, HOME)




Rare diseases (RD) have been identified as one of the paradigmatic fields in which actions conducted at the European level constitute the adequate response to their specific problems: poor recognition leading to diagnostic delay and inappropriate management including adapted social services, poor health outcomes, social burden, limited knowledge on natural history and pathophysiology leading to an insufficient development of new therapies. The low prevalence and the specificity of RD make that a global, multi-stakeholder approach, intended to gather specific expertise and to build shared strategies is necessary to address these issues.
The general objectives of RD-Action are to:
▪ Support the further development and sustainability of the Orphanet database, the biggest global repository of information on RD
▪ Contribute to solutions to ensure an appropriate codification of RD in health information systems
▪ Continue implementation of the priorities identified in Council Recommendation 2009/C151/02 and the Commission Communication (COM 2008 679) on RD, with a view to ensuring the sustainability of the recommended priority actions and to support the work of the Commission Expert Group on Rare Diseases (CEGRD).
This JA will expand and consolidate the achievements of the former JAs on RD supported by the European Commission: the Orphanet JA and the EUCERD JA. More precisely, this proposal has the ambition to help member states to implement the recommended measures adopted or to be adopted by the CEGRD and to produce the data necessary for countries to do so. Interactions between the production of data at the Orphanet database level and the implementation of policy priorities including codification will be strengthened during this JA.RD-Action large geographical coverage is key to success as it will promote the transfer of European recommendations into national policies and the collection of information and concerns from MS to the CEGRD, thus to the European Commission.

